Insider · CIK 0002071788
James Randolph Hunter Jr
Files at TNXP (Tonix Pharmaceuticals Holding Corp.). First filing -, latest -.
In brief
James Randolph Hunter Jr files SEC Form 4 as director at TNXP (Tonix Pharmaceuticals Holding Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James Randolph Hunter Jr has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +22,700 | $0.00 | $0 | 22,700 | May 14, 2026 |
| Jun 12, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +7,740 | $0.00 | $0 | 7,740 | Jun 13, 2025 |
Questions about James Randolph Hunter Jr
Answered from the filings on this page, as of the latest one.
Is James Randolph Hunter Jr buying or selling?
James Randolph Hunter Jr has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James Randolph Hunter Jr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Randolph Hunter Jr has 0.
Where does James Randolph Hunter Jr file Form 4?
James Randolph Hunter Jr has filed Form 4 at TNXP (Tonix Pharmaceuticals Holding Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.